Market Overview

UPDATE: Morgan Stanley Reiterates On Perrigo Company Following Solid Analyst Day

Share:
Related PRGO
Mylan: There's No Logic In The Teva Merger Rumor
Mylan Scores Final Win In Patent Challenge On Inhalation Drug
Teva Getting Serious About Mylan Bid, Says Report (Investor's Business Daily)

In a report published Monday, Morgan Stanley analyst David Risinger reiterated an Overweight rating on Perrigo Company (NYSE: PRGO), but removed the $167.00 price target.

In the report, Morgan Stanley noted, “Double-digit EPS growth looks durable. Perrigo hosted a comprehensive business review and outlook on Feb. 28...We were pleased that CEO Papa reiterated the company's commitment to long-term organic rev growth of 5-10% and EPS growth of 10-20%. And CFO Judy Brown characterized the Tysabri 50% royalty step-up after May 1 as a short-term booster.”

Perrigo Company closed on Friday at $164.44.

Latest Ratings for PRGO

DateFirmActionFromTo
Apr 2015Deutsche BankMaintainsBuy
Apr 2015Argus ResearchDowngradesBuyHold
Apr 2015William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for PRGO
View the Latest Analyst Ratings

Posted-In: David Risinger Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (PRGO)

Around the Web, We're Loving...